Digital We can’t fix modern healthcare with 1950s solutions. AI is t... In today’s NHS, the urgency of embracing artificial intelligence (AI) is no longer a matter of innovation - it’s a matter of survival.
Patients Responding to global greying: Does Nordic AgeTech hold the b... It’s a fact of life that we’re all living longer, which is reshaping the way healthcare is delivered.
Digital What is the future of technology in health data? From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things.
Digital From pilots to impact: What it really takes to scale GenAI i... Just a year ago, the GenAI buzz in pharma felt like the start of a gold rush. Leaders greenlit pilots. Teams spun up proof-of-concepts.
Sales & Marketing The 2025 way forward: What can UK healthcare advertising exp... Buoyed by growth opportunities and the strengthening economy, 2024 turned out to be an interesting year for the United Kingdom’s (UK) healthcare advertising industry.
R&D Tech & Trials: Recruiting is hard, AI can make it easier Recruiting for clinical trials is hard… and expensive.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.